Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 5 (2008), Issue 10 (October)

1. Self-reported psychopathological symptoms and quality of life in outpatients with bipolar disorder.
   Perspect Psychiatr Care, 44(4): 275-84. [Abstract] [Full-text]
2. Postpartum bipolar depression: a case study.
   Perspect Psychiatr Care, 44(4): 267-74. [Abstract] [Full-text]
3. Personality endophenotypes for bipolar affective disorder: a family-based genetic association analysis.
   Genes Brain Behav. [Abstract] [Full-text]
4. A common variant in the 3'UTR of the GRIK4 glutamate receptor gene affects transcript abundance and protects against bipolar disorder.
   Proc Natl Acad Sci U S A, 105(39): 14940-5. [Abstract] [Full-text]
5. Effectiveness and efficiency of cognitive-behavioral group therapy for inpatients: 4-year follow-up study.
   J Psychiatr Pract, 14(5): 281-8. [Abstract] [Full-text]
6. Pharmacologic treatment of posttraumatic stress disorder among privately insured Americans.
   Psychiatr Serv, 59(10): 1184-90. [Abstract] [Full-text]
7. Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence.
   Psychiatr Serv, 59(10): 1175-83. [Abstract] [Full-text]
8. Trends in use of antipsychotics and mood stabilizers among Medicaid beneficiaries with bipolar disorder, 2001-2004.
   Psychiatr Serv, 59(10): 1169-74. [Abstract] [Full-text]
9. High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides.
   J Proteome Res, 7(10): 4266-77. [Abstract] [Full-text]
10. Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome.
    Arch Gen Psychiatry, 65(10): 1125-33. [Abstract] [Full-text]
11. The role of the amygdala in bipolar disorder development.
    Dev Psychopathol, 20(4): 1285-96. [Abstract] [Full-text]
12. The development of antisocial behavior: what can we learn from functional neuroimaging studies?
    Dev Psychopathol, 20(4): 1145-59. [Abstract] [Full-text]
13. Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders.
    Mol Brain, 1(1): 6. [Abstract] [Full-text]
14. Reliability and validity of the Korean version of UKU-SERS-Pat in patients with bipolar disorder.
    Nord J Psychiatry. [Abstract] [Full-text]
15. Hypothesis: grandiosity and guilt cause paranoia; paranoid schizophrenia is a psychotic mood disorder; a review.
    Schizophr Bull, 34(6): 1151-62. [Abstract] [Full-text]
16. Meta-analysis of magnetic resonance imaging studies of the corpus callosum in bipolar disorder.
    Acta Psychiatr Scand, 118(5): 357-62. [Abstract] [Full-text]
17. Neuropsychological profile in bipolar disorder: a preliminary study of monotherapy lithium-treated euthymic bipolar patients evaluated at a 2-year interval.
    Acta Psychiatr Scand, 118(5): 373-81. [Abstract] [Full-text]
18. Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration.
    Acta Psychiatr Scand, 118(5): 337-46. [Abstract] [Full-text]
19. Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks.
    Acta Psychiatr Scand, 118(5): 347-56. [Abstract] [Full-text]
20. Validation of the Barcelona Bipolar Eating Disorder Scale for bipolar patients with eating disturbances.
    Psychopathology, 41(6): 379-87. [Abstract] [Full-text]
21. Recognition of mental illness and suicidality among individuals with serious mental illness.
    J Nerv Ment Dis, 196(10): 727-34. [Abstract] [Full-text]
22. Asenapine increases dopamine, norepinephrine, and acetylcholine efflux in the rat medial prefrontal cortex and hippocampus.
    Neuropsychopharmacology, 33(12): 2934-45. [Abstract] [Full-text]
23. The association between treatment adherence and antipsychotic dose among individuals with bipolar disorder.
    Int Clin Psychopharmacol, 23(6): 305-316. [Abstract] [Full-text]
24. Impact of depressive mixed state in an emergency psychiatry setting: a marker of bipolar disorder and a possible risk factor for emergency hospitalization.
    J Affect Disord, 111(1): 52-60. [Abstract] [Full-text]
25. Altered expression of neurotrophic factors in patients with major depression.
    J Psychiatr Res, 42(14): 1145-53. [Abstract] [Full-text]
26. Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania.
    Biol Psychiatry, 64(8): 718-26. [Abstract] [Full-text]
27. Bipolar pathophysiology and development of improved treatments.
    Brain Res, 1235: 92-7. [Abstract] [Full-text]
28. Brain oscillatory responses in patients with bipolar disorder manic episode before and after valproate treatment.
    Brain Res, 1235: 98-108. [Abstract] [Full-text]
29. A review of brain oscillations in cognitive disorders and the role of neurotransmitters.
    Brain Res, 1235: 172-93. [Abstract] [Full-text]
30. Abnormal corpus callosum integrity in bipolar disorder: a diffusion tensor imaging study.
    Biol Psychiatry, 64(8): 730-3. [Abstract] [Full-text]
31. Neurocognitive impairment in patients with co-occurring bipolar disorder and alcohol dependence upon discharge from inpatient care.
    Psychiatry Res, 161(1): 28-35. [Abstract] [Full-text]
32. Cognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? An ECNP expert meeting report.
    Eur Neuropsychopharmacol, 18(11): 787-93. [Abstract] [Full-text]
33. Interregional cerebral metabolic associativity during a continuous performance task (Part II) : differential alterations in bipolar and unipolar disorders.
    Psychiatry Res, 164(1): 30-47. [Abstract] [Full-text]
34. Bipolar disorders and quality of life: the impact of attention deficit/hyperactivity disorder and substance abuse in euthymic patients.
    Psychiatry Res, 161(1): 36-42. [Abstract] [Full-text]
35. Prevalence and correlates of eating disorder co-morbidity in patients with bipolar disorder.
    Psychiatry Res, 161(1): 51-8. [Abstract] [Full-text]
36. Effectiveness of lamotrigine in bipolar disorder in a clinical setting.
    J Psychiatr Res, 43(1): 13-23. [Abstract] [Full-text]
37. Psychological aspects of multiple sclerosis.
    Clin Neurol Neurosurg, 110(9): 868-77. [Abstract] [Full-text]
38. Preliminary evidence for the integration of music into HIV prevention for severely mentally ill Latinas.
    J Immigr Minor Health, 10(6): 489-95. [Abstract] [Full-text]
39. N-methyl-D-aspartate receptor and calbindin-containing neurons in the anterior cingulate cortex in schizophrenia and bipolar disorder.
    Biol Psychiatry, 64(9): 803-9. [Abstract] [Full-text]
40. Neuroimaging studies of normal brain development and their relevance for understanding childhood neuropsychiatric disorders.
    J Am Acad Child Adolesc Psychiatry, 47(11): 1233-51. [Abstract] [Full-text]
41. Regional gray matter volume deficits in adolescents with first-episode psychosis.
    J Am Acad Child Adolesc Psychiatry, 47(11): 1311-20. [Abstract] [Full-text]
42. Meta-analysis of amygdala volumes in children and adolescents with bipolar disorder.
    J Am Acad Child Adolesc Psychiatry, 47(11): 1289-98. [Abstract] [Full-text]
43. Integrating functional brain neuroimaging and developmental cognitive neuroscience in child psychiatry research.
    J Am Acad Child Adolesc Psychiatry, 47(11): 1273-88. [Abstract] [Full-text]
44. Physical victimization in prison: The role of mental illness.
    Int J Law Psychiatry, 31(5): 385-93. [Abstract] [Full-text]
45. Tolerability of oral ziprasidone in children and adolescents with bipolar mania, schizophrenia, or schizoaffective disorder.
    J Child Adolesc Psychopharmacol, 18(5): 491-9. [Abstract] [Full-text]
46. Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia.
    J Child Adolesc Psychopharmacol, 18(5): 475-90. [Abstract] [Full-text]
47. Akt/GSK3 Signaling in the Action of Psychotropic Drugs.
    Annu Rev Pharmacol Toxicol. [Abstract] [Full-text]
48. Cellular cation transport studied by (6, 7)Li and (23)Na NMR in a porous Mo(132) Keplerate type nano-capsule as model system.
    Magn Reson Chem, 46: S24-S29. [Abstract] [Full-text]
49. Different temperament and character dimensions correlate with panic disorder comorbidity in bipolar disorder and unipolar depression.
    J Anxiety Disord, 22(8): 1421-6. [Abstract] [Full-text]
50. Increased serotonin 2C receptor mRNA editing: a possible risk factor for suicide.
    Mol Psychiatry, 13(11): 1001-10. [Abstract] [Full-text]
51. The effects of a neuregulin 1 variant on white matter density and integrity.
    Mol Psychiatry, 13(11): 1054-9. [Abstract] [Full-text]
52. Regulation of brain polyunsaturated fatty acid uptake and turnover.
    Prostaglandins Leukot Essent Fatty Acids. [Abstract] [Full-text]
53. Assessing the role of cingulate cortex in bipolar disorder: Neuropathological, structural and functional imaging data.
    Brain Res Rev, 59(1): 9-21. [Abstract] [Full-text]
54. Functional brain abnormalities in psychiatric disorders: Neural mechanisms to detect and resolve cognitive conflict and interference.
    Brain Res Rev, 59(1): 96-124. [Abstract] [Full-text]
55. Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors.
    Eur J Pharmacol, 597(1): 27-33. [Abstract] [Full-text]
56. The copy number variant involving part of the alpha7 nicotinic receptor gene contains a polymorphic inversion.
    Eur J Hum Genet, 16(11): 1364-71. [Abstract] [Full-text]
57. Brain-derived neurotrophic factor Val/Met polymorphism and bipolar disorder. Association of the Met allele with suicidal behavior of bipolar patients.
    Neuropsychobiology, 58(2): 97-103. [Abstract] [Full-text]
58. Comorbidity of adult attention-deficit hyperactivity disorder and bipolar disorder: prevalence and clinical correlates.
    Eur Arch Psychiatry Clin Neurosci, 258(7): 385-93. [Abstract] [Full-text]
59. Biochemical changes in the cingulum in patients with schizophrenia and chronic bipolar disorder.
    Eur Arch Psychiatry Clin Neurosci, 258(7): 394-401. [Abstract] [Full-text]
60. 5-ht2c receptor and mao-a interaction analysis: no association with suicidal behaviour in bipolar patients.
    Eur Arch Psychiatry Clin Neurosci, 258(7): 428-33. [Abstract] [Full-text]
61. The treated prevalence and incidence of bipolar disorder among national health insurance enrollees in Taiwan, 1996-2003.
    Soc Psychiatry Psychiatr Epidemiol, 43(11): 860-5. [Abstract] [Full-text]
62. Cognitive functions in bipolar affective disorder and schizophrenia: comparison.
    Psychiatry Clin Neurosci, 62(5): 515-25. [Abstract] [Full-text]
63. Temporal lobe and "default" hemodynamic brain modes discriminate between schizophrenia and bipolar disorder.
    Hum Brain Mapp, 29(11): 1265-75. [Abstract] [Full-text]
64. High prevalence of bipolar disorder comorbidity in adolescents and young adults with high-functioning autism spectrum disorder: a preliminary study of 44 outpatients.
    J Affect Disord, 111(2): 170-5. [Abstract] [Full-text]
65. Are hypomanics the happier normals?
    J Affect Disord, 111(2): 235-43. [Abstract] [Full-text]
66. Only half of bipolar I and II patients report prodromal symptoms.
    J Affect Disord, 111(2): 366-71. [Abstract] [Full-text]
67. Oxidative stress markers in bipolar disorder: a meta-analysis.
    J Affect Disord, 111(2): 135-44. [Abstract] [Full-text]
68. Electroconvulsive therapy for bipolar depressive and mixed episode with high suicide risk after epilepsy surgery.
    Epilepsy Behav, 13(4): 707-9. [Abstract] [Full-text]
69. Cloning, expression, and functional analysis of rhesus monkey trace amine-associated receptor 6: evidence for lack of monoaminergic association.
    J Neurosci Res, 86(15): 3435-46. [Abstract] [Full-text]
70. On the prevalence of bipolar disorder in epilepsy.
    Epilepsy Behav, 13(4): 658-61. [Abstract] [Full-text]
71. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.
    J Affect Disord, 111(2): 306-19. [Abstract] [Full-text]
72. Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.
    Psychiatry Res, 161(2): 131-41. [Abstract] [Full-text]
73. Decision making in bipolar disorder: a cognitive modeling approach.
    Psychiatry Res, 161(2): 142-52. [Abstract] [Full-text]
74. A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression.
    J Affect Disord, 111(2): 334-43. [Abstract] [Full-text]
75. SNAP-25 genotype influences NAA/Cho in left hippocampus.
    J Neural Transm, 115(11): 1513-8. [Abstract] [Full-text]
76. Long-chain omega-3 polyunsaturated Fatty acids in the blood of children and adolescents with juvenile bipolar disorder.
    Lipids, 43(11): 1031-8. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.